With teens relying heavily on their friends and social connections for emotional support, the restrictions imposed to contain COVID-19 are especially hard on them. The C.S. Mott Children’s Hospital National Poll on Children’s Health asked a national sample of parents about the emotional impact pandemic restrictions have had on their teens aged 13 to 18.
Although the use of antidepressants to treat treatment-resistant bipolar depression (TRD-BD) is common, due to the theoretical continuum between treatment-resistant unipolar depression and TRD-BD, the practice is nevertheless controversial.
With the prevalence of childhood obesity steadily rising, there is a need for the greater understanding of the relationship between childhood obesity and mood disorders.
Study researchers examined the prevalence of major depressive disorder (MDD) during COVID-19 among US residents with and without a history of depressive disorders and the associations of current MDD with changes in negative and positive health behaviors.
The study authors aimed to assess the real-world effectiveness of fremanezumab in patients with migraine and major depressive disorder or generalized anxiety disorder.
Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.
